These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 21325218)

  • 41. Langerhans cell dogma: another round of rejections.
    Udey MC; Rosenberg AS
    J Invest Dermatol; 2008 Aug; 128(8):1881-3. PubMed ID: 18626480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pillars Article: Peculiar Immunobiology of Bone Marrow Allografts: II. Rejection of Parental Grafts by Resistant FI Hybrid Mice. J Exp Med. 1971. 134: 1513-1528.
    Cudkowicz G; Bennett M
    J Immunol; 2015 Oct; 195(7):2946-61. PubMed ID: 26386037
    [No Abstract]   [Full Text] [Related]  

  • 43. Tumor necrosis factor-alpha is persistently expressed in cardiac allografts in the absence of histological or clinical evidence of rejection.
    Torre-Amione G; MacLellan W; Kapadia S; Weilbaecher D; Farmer J; Young J; Mann D
    Transplant Proc; 1998 May; 30(3):875-7. PubMed ID: 9595133
    [No Abstract]   [Full Text] [Related]  

  • 44. Pregnancy site-specific tolerance to allogeneic fetus.
    Cai CC; Rathod H; Chen ZK
    Transplant Proc; 2000 Nov; 32(7):2496-7. PubMed ID: 11120264
    [No Abstract]   [Full Text] [Related]  

  • 45. Allogeneic heart graft rejection in mice: correlation between mononuclear cell infiltration and extracellular matrix deposition.
    Riederer I; Silva-Barbosa SD; Savino W
    Transplant Proc; 2002 Jun; 34(4):1076-8. PubMed ID: 12072281
    [No Abstract]   [Full Text] [Related]  

  • 46. Rejection of alphaGAL mismatched skin grafts: a model of acute vascular rejection?
    Iacomini J
    Transplantation; 2002 Sep; 74(5):599-600. PubMed ID: 12357986
    [No Abstract]   [Full Text] [Related]  

  • 47. Direct pathway T-cell alloactivation is more rapid than indirect pathway alloactivation.
    Gupta S; Balasubramanian S; Thornley TB; Strom TB; Kenny JJ
    Transplantation; 2011 May; 91(9):e65-7. PubMed ID: 21508799
    [No Abstract]   [Full Text] [Related]  

  • 48. A comparison of skin and heart graft rejection patterns in H-2 mutant mice.
    Davis WC; McKenzie IF; Melvold RW
    Transplantation; 1980 Mar; 29(3):189-92. PubMed ID: 6987783
    [No Abstract]   [Full Text] [Related]  

  • 49. Recent state of cyclophosphamide-induced skin allograft tolerance in mice.
    Fontalin LN; Chernyakhovskaya IYu
    Immunobiology; 1991 Jun; 182(3-4):323-33. PubMed ID: 1916879
    [No Abstract]   [Full Text] [Related]  

  • 50. Chronic chagasic cardiopathy: role of CD4 T cells in the anti-heart autoreactivity.
    Dos Santos RR; Laus JL; Mengel JO; Savino W
    Mem Inst Oswaldo Cruz; 1990; 85(3):367-9. PubMed ID: 2134712
    [No Abstract]   [Full Text] [Related]  

  • 51. Prolongation of skin allograft survival in antilymphocyte serum-treated mice by posttransplant administration of peripheral blood lymphocytes.
    De Fazio SR; Monaco AP; Gozzo JJ
    Transplantation; 1989 Jul; 48(1):163-5. PubMed ID: 2665227
    [No Abstract]   [Full Text] [Related]  

  • 52. Prolongation of the survival of murine cardiac allografts by the vitamin D3 analogue 1,25-dihydroxy-delta 16-cholecalciferol.
    Lemire JM; Archer DC; Khulkarni A; Ince A; Uskokovic MR; Stepkowski S
    Transplantation; 1992 Oct; 54(4):762-3. PubMed ID: 1412777
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunological enhancement can be mediated by anti-Ia and anti-K,D antibodies.
    Davis WC; McKenzie IF
    Transplantation; 1980; 29(1):77-9. PubMed ID: 6989043
    [No Abstract]   [Full Text] [Related]  

  • 54. Prolongation of mouse skin allograft survival by novel agonists selective for retinoic acid receptor-alpha.
    Seino K; Yamauchi T; Ishibashi A; Tokuhara N; Kobayashi S; Fukunaga K; Taniguchi H; Takada Y; Yuzawa K; Otsuka M; Todoroki T; Fukao K
    Transplant Proc; 2000 Mar; 32(2):257-8. PubMed ID: 10715409
    [No Abstract]   [Full Text] [Related]  

  • 55. Antigen-specific clone selection in vivo.
    Miller JF
    Immunol Cell Biol; 2008 Jan; 86(1):24-5. PubMed ID: 17998913
    [No Abstract]   [Full Text] [Related]  

  • 56. Production of H-Y antibody by female mice that fail to reject male skin.
    Goldberg E; Boyse EA; Scheid M; Bennett D
    Nat New Biol; 1972 Jul; 238(80):55-7. PubMed ID: 18663856
    [No Abstract]   [Full Text] [Related]  

  • 57. Cynomolgus monkey did not hyperacutely reject skin xenograft of N-acetylglucosaminyltransferase III gene transgenic pig.
    Fujita T; Machida K; Matsumoto Y; Saito T; Sato N; Takahagi Y; Murakami H; Miyagawa S; Shirakura R; Taniguchi N
    Transplant Proc; 2003 Feb; 35(1):518. PubMed ID: 12591511
    [No Abstract]   [Full Text] [Related]  

  • 58. Editorial: protean effects of IL-10 include skin self-defense.
    Fowler DH
    J Leukoc Biol; 2012 Aug; 92(2):247-8. PubMed ID: 22850765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD40-CD40L Blockade: Update on Novel Investigational Therapeutics for Transplantation.
    Singh AK; Goerlich CE; Zhang T; Lewis BGT; Hershfeld A; Mohiuddin MM
    Transplantation; 2023 Jul; 107(7):1472-1481. PubMed ID: 36584382
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevated T cell levels in peripheral blood predict poor clinical response following rituximab treatment in new-onset type 1 diabetes.
    Linsley PS; Greenbaum CJ; Rosasco M; Presnell S; Herold KC; Dufort MJ
    Genes Immun; 2019 Apr; 20(4):293-307. PubMed ID: 29925930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.